Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interstitial Fibrosis/Tubular Atrophy of Transplanted Kidneys”

8 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 8 of 8 results

Not applicableStudy completedNCT01289717
What this trial is testing

Proteogenomic Biomarker Panels in a Serial Blood & Urine Monitoring Study of Kidney Transplant Recipients

Who this might be right for
Kidney TransplantKidney Transplantation
National Institute of Allergy and Infectious Diseases (NIAID) 307
Not applicableLooking for participantsNCT01531257
What this trial is testing

Proteogenomic Monitoring and Assessment of Kidney Transplant Recipients

Who this might be right for
Acute Rejection (AR) of Transplanted KidneyChronic Allograft Nephropathy (CAN)Interstitial Fibrosis (IF)+1 more
Northwestern University 1,000
Testing effectiveness (Phase 2)Enrolling By InvitationNCT05285878
What this trial is testing

Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Interstitial FibrosisKidney Transplant; ComplicationsKidney Transplant Rejection+4 more
The Methodist Hospital Research Institute 20
Not applicableStudy completedNCT03918161
What this trial is testing

Magnetic Resonance Elastography of Transplanted Kidney (GREFFE_ELASTO IRM)

Who this might be right for
Interstitial Fibrosis/Tubular Atrophy of Transplanted Kidneys
University Hospital, Bordeaux 73
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06751602
What this trial is testing

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Rejection Chronic Renal
The Methodist Hospital Research Institute 40
Large-scale testing (Phase 3)Study completedNCT01079143
What this trial is testing

Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

Who this might be right for
Renal Interstitial Fibrosis
Novartis Pharmaceuticals 194
Testing effectiveness (Phase 2)WithdrawnNCT00878761
What this trial is testing

Study of STX-100 in Renal Transplant Patients With Interstitial Fibrosis and Tubular Atrophy (IF/TA)

Who this might be right for
Chronic Allograft Dysfunction
Stromedix, Inc. 48
Post-approval studies (Phase 4)Study completedNCT00637143
What this trial is testing

Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)

Who this might be right for
Renal TransplantationChronic Renal Allograft Failure
Astellas Pharma Inc 107